Related Experiment Videos
Essential hypertension and insulin resistance
R Dzúrik1, J Málková, V Spustová
1Centre of Clinical Pharmacology, Institute of Preventive and Clinical Medicine, Bratislava, Czechoslovakia.
Cor Et Vasa
|January 1, 1991
Summary
Insulin resistance (IR) is a key risk factor for hypertension and atherosclerosis, affecting metabolism. Diagnosis involves glucose tolerance tests, but treatment remains challenging, though research shows promise.
Area of Science:
- Endocrinology and Metabolism
- Cardiovascular Disease Research
Background:
- Insulin resistance (IR) is linked to hypertension and atherosclerosis.
- IR is also prevalent in obesity, dyslipidaemia, and type 2 diabetes.
- It can be observed in untreated hypertension and in children of hypertensive parents.
Purpose of the Study:
- To explore the role of insulin resistance in hypertension and atherosclerosis.
- To discuss diagnostic methods for insulin resistance.
- To review current treatment strategies and future research directions.
Main Methods:
- Diagnosis of IR through insulin and glycaemia measurements during a glucose tolerance test.
- Review of existing literature on IR, hypertension, and related metabolic disorders.
Main Results:
- Insulin resistance alters carbohydrate, lipid, and protein metabolism.
- IR is implicated in the development of hypertension.
- Differential diagnosis is crucial as IR is not exclusive to hypertension.
Conclusions:
- Insulin resistance is a significant risk factor for cardiovascular conditions.
- Current pharmacological treatments for IR are limited, with non-pharmacological measures being primary.
- Emerging research offers promising avenues for future therapeutic interventions.